WAVE Life Sciences Q2 EPS $(0.20) Beats $(0.32) Estimate, Sales $22.11M Beat $8.08M Estimate
Portfolio Pulse from Benzinga Newsdesk
WAVE Life Sciences reported Q2 earnings per share of $(0.20), beating the analyst consensus estimate of $(0.32) by 37.5%. The company also reported quarterly sales of $22.11 million, surpassing the analyst consensus estimate of $8.08 million by 173.59%. This represents a significant increase from the same period last year.
August 04, 2023 | 1:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
WAVE Life Sciences reported better than expected Q2 earnings and sales, which could positively impact its stock price.
WAVE Life Sciences reported Q2 earnings and sales that significantly beat analyst estimates. This positive financial performance could increase investor confidence and drive up the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100